Annual Working Capital
$20.48 M
-$30.25 M-59.63%
30 September 2022
Summary:
NeuBase Therapeutics annual working capital is currently $20.48 million, with the most recent change of -$30.25 million (-59.63%) on 30 September 2022. During the last 3 years, it has fallen by -$30.25 million (-59.63%).NBSE Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$8.70 M
-$692.60 K-7.37%
30 September 2023
Summary:
NeuBase Therapeutics quarterly working capital is currently $8.70 million, with the most recent change of -$692.60 thousand (-7.37%) on 30 September 2023.NBSE Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBSE Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -59.6% | -82.8% |
| 5 y5 years | +140.2% | +2.0% |
NBSE Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -59.6% | -84.8% |
NeuBase Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $8.70 M(-7.4%) |
| June 2023 | - | $9.39 M(-23.6%) |
| Mar 2023 | - | $12.29 M(-22.3%) |
| Dec 2022 | - | $15.82 M(-22.8%) |
| Sept 2022 | $20.48 M(-59.6%) | $20.48 M(-25.3%) |
| June 2022 | - | $27.42 M(-22.2%) |
| Mar 2022 | - | $35.23 M(-20.5%) |
| Dec 2021 | - | $44.34 M(-12.6%) |
| Sept 2021 | $50.73 M(+71.1%) | $50.73 M(-11.1%) |
| June 2021 | - | $57.08 M(+166.7%) |
| Mar 2021 | - | $21.40 M(-19.5%) |
| Dec 2020 | - | $26.58 M(-10.4%) |
| Sept 2020 | $29.66 M(+247.8%) | $29.66 M(-11.2%) |
| June 2020 | - | $33.42 M(+1118.7%) |
| Mar 2020 | - | $2.74 M(-51.8%) |
| Dec 2019 | - | $5.68 M(-33.3%) |
| Sept 2019 | $8.53 M(+3997.6%) | $8.53 M(+957.4%) |
| June 2019 | - | $806.40 K(-52.8%) |
| Mar 2019 | - | $1.71 M(-34.8%) |
| Dec 2018 | - | $2.62 M(+1157.3%) |
| Sept 2018 | $208.10 K(-97.4%) | $208.10 K(-94.7%) |
| June 2018 | - | $3.96 M(-3.5%) |
| Mar 2018 | - | $4.11 M(-21.5%) |
| Dec 2017 | - | $5.23 M(-35.4%) |
| Sept 2017 | $8.09 M(-8.1%) | $8.09 M(-37.4%) |
| June 2017 | - | $12.92 M(+323.7%) |
| Mar 2017 | - | $3.05 M(-69.4%) |
| Dec 2016 | - | $9.97 M(+13.3%) |
| Sept 2016 | $8.80 M(-65.0%) | $8.80 M(-29.9%) |
| June 2016 | - | $12.56 M(-33.3%) |
| Mar 2016 | - | $18.82 M(-13.8%) |
| Dec 2015 | - | $21.83 M(-13.2%) |
| Sept 2015 | $25.16 M(+211.3%) | $25.16 M(-10.0%) |
| June 2015 | - | $27.95 M(-7.8%) |
| Mar 2015 | - | $30.31 M(+614.1%) |
| Dec 2014 | - | $4.24 M(-47.5%) |
| Sept 2014 | $8.08 M | $8.08 M(-3.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2014 | - | $8.33 M(+197.9%) |
| Mar 2014 | - | $2.80 M(-26.1%) |
| Dec 2013 | - | $3.79 M(-19.3%) |
| Sept 2013 | $4.69 M(+166.5%) | $4.69 M(-21.9%) |
| June 2013 | - | $6.01 M(+262.7%) |
| Mar 2013 | - | $1.66 M(-1684.8%) |
| Dec 2012 | - | -$104.50 K(-105.9%) |
| Sept 2012 | $1.76 M(-132.0%) | $1.76 M(-443.9%) |
| June 2012 | - | -$511.70 K(-63.6%) |
| Mar 2012 | - | -$1.40 M(-66.4%) |
| Dec 2011 | - | -$4.18 M(-24.0%) |
| Sept 2011 | -$5.50 M(+363.6%) | -$5.50 M(-1040.2%) |
| June 2011 | - | $585.30 K(-29.5%) |
| Mar 2011 | - | $829.80 K(+70.3%) |
| Dec 2010 | - | $487.30 K(-141.1%) |
| Sept 2010 | -$1.19 M(-1381.9%) | -$1.19 M(-320.4%) |
| June 2010 | - | $538.50 K(-16.4%) |
| Mar 2010 | - | $644.50 K(+235.2%) |
| Dec 2009 | - | $192.30 K(+107.7%) |
| Sept 2009 | $92.60 K(-278.8%) | $92.60 K(-66.8%) |
| June 2009 | - | $279.00 K(-160.4%) |
| Mar 2009 | - | -$462.00 K(+291.5%) |
| Dec 2008 | - | -$118.00 K(+127.8%) |
| Sept 2008 | -$51.80 K(-88.2%) | -$51.80 K(+23.3%) |
| June 2008 | - | -$42.00 K(-20.8%) |
| Mar 2008 | - | -$53.00 K(-88.0%) |
| Sept 2007 | -$440.00 K(<-9900.0%) | -$440.00 K(-304.7%) |
| Mar 2007 | - | $215.00 K(+1620.0%) |
| Mar 2006 | - | $12.50 K(+247.2%) |
| Dec 2005 | $3600.00(-98.6%) | $3600.00(-99.0%) |
| Sept 2005 | - | $363.40 K(+26.0%) |
| June 2005 | - | $288.50 K(-28.3%) |
| Mar 2005 | - | $402.60 K(+57.0%) |
| Dec 2004 | $256.40 K(+6.7%) | $256.40 K(-26.0%) |
| Sept 2004 | - | $346.60 K(-47.2%) |
| June 2004 | - | $656.80 K(-1860.9%) |
| Mar 2004 | - | -$37.30 K |
| Dec 2003 | $240.20 K | - |
FAQ
- What is NeuBase Therapeutics annual working capital?
- What is the all time high annual working capital for NeuBase Therapeutics?
- What is NeuBase Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for NeuBase Therapeutics?
What is NeuBase Therapeutics annual working capital?
The current annual working capital of NBSE is $20.48 M
What is the all time high annual working capital for NeuBase Therapeutics?
NeuBase Therapeutics all-time high annual working capital is $50.73 M
What is NeuBase Therapeutics quarterly working capital?
The current quarterly working capital of NBSE is $8.70 M
What is the all time high quarterly working capital for NeuBase Therapeutics?
NeuBase Therapeutics all-time high quarterly working capital is $57.08 M